D. E. Shaw & Co., Inc. Agios Pharmaceuticals, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $2.24 Million - $3.77 Million	-75,800 Reduced 71.64%	30,000 $986,000
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $813,216 - $1.39 Million	25,800 Added 32.25%	105,800 $3.75 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $300,800 - $505,900	10,000 Added 14.29%	80,000 $3.82 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $1.78 Million - $2.73 Million	55,000 Added 366.67%	70,000 $2.27 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $640,950 - $1.15 Million	15,000 New	15,000 $692,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.76B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.